The BGR Brief – A Shift On Psychedelics with John Stone

Fresh off this weekend’s landmark Executive Order, BGR Health & Life Sciences Principal John Stone breaks down the President’s steps to fast-track psychedelic therapies. John explains how the administration is leveraging the MAHA agenda to embrace alternative treatments, the new role for the DEA in patient access, and what the $50 million research push means for the veterans community.